HomeCompareBLUIX vs JNJ

BLUIX vs JNJ: Dividend Comparison 2026

BLUIX yields 4.45% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BLUIX wins by $6.7K in total portfolio value
10 years
BLUIX
BLUIX
● Live price
4.45%
Share price
$15.76
Annual div
$0.70
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$592.61
Full BLUIX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BLUIX vs JNJ

📍 BLUIX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBLUIXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BLUIX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BLUIX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BLUIX
Annual income on $10K today (after 15% tax)
$378.62/yr
After 10yr DRIP, annual income (after tax)
$503.72/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $199.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BLUIX + JNJ for your $10,000?

BLUIX: 50%JNJ: 50%
100% JNJ50/50100% BLUIX
Portfolio after 10yr
$23.4K
Annual income
$710.20/yr
Blended yield
3.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BLUIX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BLUIX buys
0
JNJ buys
0
No recent congressional trades found for BLUIX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBLUIXJNJ
Forward yield4.45%3.36%
Annual dividend / share$0.70$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.8K$20.0K
Annual income after 10y$592.61$827.78
Total dividends collected$5.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BLUIX vs JNJ ($10,000, DRIP)

YearBLUIX PortfolioBLUIX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,145$445.43$10,676$355.77+$469.00BLUIX
2$12,390$463.97$11,407$389.39+$983.00BLUIX
3$13,739$482.03$12,198$426.53+$1.5KBLUIX
4$15,200$499.55$13,056$467.62+$2.1KBLUIX
5$16,781$516.53$13,987$513.12+$2.8KBLUIX
6$18,488$532.93$14,998$563.56+$3.5KBLUIX
7$20,331$548.75$16,098$619.52+$4.2KBLUIX
8$22,318$563.97$17,295$681.69+$5.0KBLUIX
9$24,459$578.59$18,599$750.82+$5.9KBLUIX
10$26,764$592.61$20,022$827.78+$6.7KBLUIX

BLUIX vs JNJ: Complete Analysis 2026

BLUIXStock

Under normal market conditions, the fund will seek growth through capital appreciation by investing in individual securities and shares of other investment companies, including exchange-traded funds ("ETFs"), open-end mutual funds, and closed-end funds. It may hold equity securities, either directly or indirectly, of all capitalizations, and may indirectly hold fixed-income securities of all credit qualities.

Full BLUIX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BLUIX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BLUIX vs SCHDBLUIX vs JEPIBLUIX vs OBLUIX vs KOBLUIX vs MAINBLUIX vs ABBVBLUIX vs MRKBLUIX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.